Physician profile
Moethu Win
NPI 1063525285
$13,339.67
in general payments reported to CMS, 2019-2025
39 companies · $1,666 in 2025
The $1,666 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,419 · 2020: $1,211 · 2021: $1,463 · 2022: $1,102 · 2023: $3,548 · 2024: $2,929 · 2025: $1,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,046 · Travel and Lodging: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,045.66 |
| Travel and Lodging | $1,098.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,876.56 | 2021-2025 | Onyx Frontier, Ellipsys Vascular Access System, Hawkone |
| Philips North America LLC | $1,532.40 | 2019-2025 | Labosys, (Ck7) Extended Holter, (Bk5) Azurion 5 M20 |
| Inari Medical, INC. | $1,118.02 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $848.19 | 2019-2025 | Ekosonic, Watchman Access System, General - Tachy |
| Penumbra, INC. | $717.80 | 2022-2023 | Ruby Coil |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $575.73 | 2020-2025 | Lifevest |
| Cardiovascular Systems INC. | $502.66 | 2019-2023 | |
| Biotronik INC. | $407.96 | 2022-2025 | Pulsar-18 T3, Amvia Edge, Oscar |
| Bard Peripheral Vascular, INC. | $367.14 | 2024-2025 | Crosser Iq, Rotarexs 6 F X 135 Cm |
| Medtronic Vascular, INC. | $329.44 | 2019-2020 | |
| Stryker Corporation | $328.60 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $279.28 | 2019-2025 | Jardiance |
| Abbott Laboratories | $231.38 | 2019-2025 | Esprit, Diamondback Peripheral, Confirm Rx |
| Janssen Pharmaceuticals, INC | $214.51 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $179.23 | 2019-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $176.14 | 2020 | |
| Abiomed | $170.41 | 2025 | |
| Cvrx, INC. | $155.23 | 2022-2024 | Barostim Neo System |
| Teleflex LLC | $136.79 | 2025 | Pulsar-18 T3 |
| Amarin Pharma, INC. | $129.88 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $122.37 | 2019-2023 | Farxiga |
| Canon Medical Systems USA, INC. | $104.22 | 2020 | |
| Kestra Medical Technology Services, INC. | $100.59 | 2024-2025 | Assure Wcd |
| Astellas Pharma US INC | $90.99 | 2019 | |
| Pfizer INC. | $73.03 | 2019-2024 | |
| Edwards Lifesciences Corporation | $70.30 | 2019-2025 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $64.61 | 2021-2024 | Eliquis, Camzyos |
| Shockwave Medical, INC | $56.02 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baylis Medical Company INC | $50.50 | 2021 | |
| Cook Medical LLC | $47.77 | 2024 | Zilver Ptx, Torcon Nb, Cook Celect |
| Bardy Diagnostics, INC. | $47.00 | 2020-2022 | |
| Amgen INC. | $46.43 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $42.63 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $36.45 | 2021-2023 | Verquvo |
| Lundbeck LLC | $32.52 | 2019 | |
| Cardinal Health 200 LLC | $24.22 | 2020 | |
| Angiodynamics, INC. | $19.47 | 2024 | Venacure 1470 Pro |
| Scpharmaceuticals INC. | $18.65 | 2023 | |
| Alnylam Pharmaceuticals INC. | $14.55 | 2023 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moethu Win listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.